DONATE

Researchers develop a device that replicates tumours to study the efficacy of immunotherapy treatments

The Micro Immune Response On chip (MIRO) allows tumours and their environment to be replicated in order to understand their response to treatment. The device, which has already been successfully tested on breast cancer samples, could be key to developing new treatments and determining the most appropriate therapy for each patient in a personalized way. The work, published in Nature Communications, is the result of a collaboration between the Institute for Bioengineering of Catalonia and the Research Institute of the Hospital del Mar.

Nanomed Europe

NME25 celebrates the 20th anniversary of ETPN and Nanomed Spain, hosted across multiple venues in Barcelona. This landmark event brings together ETPN’s vast network of scientists, innovators, industry leaders, and … Read more

IBEC Seminar: Prof. Joo H. Kang and Prof. Jinmyoung Joo

Microfluidic Approaches for Infection Treatment and Vascularized Tissue Regeneration Joo H. Kang, Ph.D., Associate Professor Department of Biomedical Engineering, Ulsan National Institute of Science and Technology  Extracorporeal blood treatments for … Read more